We use cookies to ensure that we give you the best experience on our website.
When you use our platform without an account you need to read and accept the
Terms of Service, Data Policy and Disclaimer(s).
Drug Manufacturers - General
Healthcare
US
North Chicago
IR
Market Cap.:305.5 B
XL
Market Capitalization - Sizes
Here you can see how we classify a market capitalization.
XS
< 100 Mil.
S
> 100 Mil.
M
> 1 Bil.
L
> 10 Bil.
XL
> 100 Bil.
P/E:64.30
x34.52Industry Within Country Benchmark (IWCB)
The multiplier shows you the relation between a reported metric, e.g. Earnings Per Share (EPS)
and the μ EPS value of the corporate's industry.
We exclude other countries from the average calculation in order to
take into account the specific economic and regulatory conditions in that country.
Concrete for "Drug Manufacturers—General" in United States
EPS: 3.6086,
P/E: 34.5167
EPS:2.69
x
1.34
Industry Within Country Benchmark (IWCB)
The multiplier shows you the relation between a reported metric, e.g. Earnings Per Share (EPS)
and the μ EPS value of the corporate's industry.
We exclude other countries from the average calculation in order to
take into account the specific economic and regulatory conditions in that country.
Concrete for Drug Manufacturers—General in United States
EPS: 3.6086,
P/E: 34.5167
Earnings Call
1 month from now
Dividend Waiting Time
We compute the average time difference between dividend payments
and assign an indicator that holds a general grade for that frequency.
Low
Average time between dividend payments is less than 3 months.
Neutral
Average time between dividend payments is between 3 to 6 months.
High
Average time between dividend payments is more than 6 months.
n.A.
Latest Dividends History
Each bar represents a dividend payment made within the last 12 months, with the bar's height relative to the maximum dividend paid within that timeframe.
See all Dividends.
Volume LevelVolume Deviation Rating System (VDRS)
We compare the 15-minute delayed volume to the average volume and grade the percentual deviation.
High
Deviation >= 20%
Moderate High
Deviation between 10% to 20%
Moderate
Deviation between -10% to 10%
Moderate Low
Deviation between -20% to -10%
Low
Deviation between <= -20%
μ 624
802
Moderate Low
Performance Ranks (Intraday)A system to benchmark 4AB.DE's relative intraday performance.
Each star represents "20% have worse results", e.g. 4/5 stars symbolize that the corporate had a better result than 80% of the benchmark compotion.
United States:
2033rd
out of
2160
Healthcare:
693rd
out of
792
Drug Manufacturers—General:
56th
out of
62
Peer Group:
3rd
out of
5
About
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults;
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis …
About
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults;
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis …
Berkshire Hathaway
Profile, Qualitative, Financials ...
Overview
Royal Bank Of Canada
Valuation Models & History
Financials
Alphabet Inc. - Competitors
SNAP, TWLO, PINS, META ...
Comp.
Amazon.com, Inc.
Risks/AI
NLP Analyzed Risk Factors, AI Arguments
Apple Inc. vs. Peers & Industry Benchmarks
Benchmarks Industry
Peter Lynch Screener
Strategy